These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9639254

  • 21. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation.
    Smith AJ, Patel S, Freedman SB.
    Eur J Pharmacol; 1994 Apr 15; 267(2):215-23. PubMed ID: 8050481
    [Abstract] [Full Text] [Related]

  • 22. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.
    Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H.
    Arch Gen Psychiatry; 1994 Jun 15; 51(6):486-93. PubMed ID: 8192551
    [Abstract] [Full Text] [Related]

  • 23. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E.
    Neuropeptides; 1999 Feb 15; 33(1):63-9. PubMed ID: 10657473
    [Abstract] [Full Text] [Related]

  • 24. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
    Lucaites VL, Mendelsohn LG, Mason NR, Cohen ML.
    J Pharmacol Exp Ther; 1991 Feb 15; 256(2):695-703. PubMed ID: 1704435
    [Abstract] [Full Text] [Related]

  • 25. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL, Fouraux MA, van Emst-de Vries SE, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Mar 15; 123(6):1189-97. PubMed ID: 9559904
    [Abstract] [Full Text] [Related]

  • 26. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.
    J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283
    [Abstract] [Full Text] [Related]

  • 27. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.
    Aliment Pharmacol Ther; 1997 Feb 08; 11(1):113-20. PubMed ID: 9042983
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S, Gusdinar T, Bali JP, Magous R.
    Biochem Pharmacol; 1991 Jul 25; 42(4):771-6. PubMed ID: 1714276
    [Abstract] [Full Text] [Related]

  • 30. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
    Männistö PT, Peuranen E, Harro J, Vasar E.
    Neuropeptides; 1992 Dec 25; 23(4):251-8. PubMed ID: 1475033
    [Abstract] [Full Text] [Related]

  • 31. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
    Mercer JG, Lawrence CB.
    Neurosci Lett; 1992 Mar 30; 137(2):229-31. PubMed ID: 1374868
    [Abstract] [Full Text] [Related]

  • 32. Biological effects of newly synthesized cholecystokinin analogs.
    Verspohl EJ, LaMura M.
    Horm Res; 2000 Mar 30; 53(4):177-84. PubMed ID: 11044801
    [Abstract] [Full Text] [Related]

  • 33. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y, Shulkes A.
    J Physiol; 1997 Dec 15; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [Abstract] [Full Text] [Related]

  • 34. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 15; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 35. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
    Günther R, Carstens OC, Schmidt WE, Fölsch UR.
    Pancreatology; 2003 Aug 15; 3(1):47-54. PubMed ID: 12649564
    [Abstract] [Full Text] [Related]

  • 36. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR, Woodruff GN.
    Brain Res; 1990 Sep 03; 526(2):276-83. PubMed ID: 2257485
    [Abstract] [Full Text] [Related]

  • 37. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
    Beinborn M, Chen C, DeMeo L, McBride EW, Kopin AS.
    Yale J Biol Med; 1998 Sep 03; 71(3-4):337-46. PubMed ID: 10461364
    [Abstract] [Full Text] [Related]

  • 38. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May 03; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 39. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Jul 03; 124(5):935-45. PubMed ID: 9692779
    [Abstract] [Full Text] [Related]

  • 40. Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells.
    Schaeffer P, Nestor AL, Prabonnaud V, Bachy A, Laplace MC, Keane PE, Bignon E, Herbert JM.
    Eur J Pharmacol; 2000 Jun 02; 397(2-3):303-10. PubMed ID: 10844128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.